A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving ...

Bunnie XO shares her harrowing experience with an experimental weight-loss drug, describing severe depression and suicidal ...

Changes in purchasing patterns after glucagon-like peptide-1 receptor agonist (GLP-1RA) initiation were seen across most nutrient ...

Sun Pharma receives DCGI approval to launch generic Wegovy semaglutide in India after patent expiry in March 2026. Check ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

The pill version of Wegovy seems to work just as well as the injectable form, but there are some key differences between the ...

US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...

ALV-100 is a bifunctional glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist / glucagon-like peptide-1 receptor (GLP-1R) agonist fusion protein designed to address long-term ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most common side effect of semaglutide, the ...

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...